Search Results - "Slobodin, G"

Von Willebrand factor: a possible biomarker for disease activity in vasculitis by Keret, S, Mazareeb, J, Snir, A, Shouval, A, Awisat, A, Kaly, L, Rosner, I, Rozenbaum, M, Boulman, N, Hardak, E, Slobodin, G, Rimar, D

“…Inflammation markers, e.g. C- reactive protein (CRP) and sedimentation rate, can be normal despite active vasculitis. Von Willebrand factor (vWF) is secreted…”
Get full text

Calcinosis in Rheumatic Diseases by Boulman, Nina, Slobodin, Gleb, Rozenbaum, Michael, Rosner, Itzhak

“…Calcinosis, or dystrophic soft-tissue calcification, occurs in damaged or devitalized tissues in the presence of normal calcium/phosphorus metabolism. It is…”
Get full text

Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy by SNIR, A, KESSEL, A, HAJ, T, ROSNER, I, SLOBODIN, G, TOUBI, E

“…IL-6 mediated inflammation is induced by binding to IL-6 receptor (IL-6R) or IL-6/IL-6R complex binding gp130. Tocilizumab, a recombinant humanised monoclonal…”
Get full text

Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis by Toubi, E, Kessel, A, Slobodin, G, Boulman, N, Pavlotzky, E, Zisman, D, Rozenbaum, M, Rosner, I

“…Objective: To assess changes in macrophage phenotype and function after rituximab-induced B cell depletion in patients with rheumatoid arthritis (RA). Methods:…”
Get full text

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy by Rosner, I., Haddad, A., Boulman, N., Feld, J., Avshovich, N., Slobodin, G., Rozenbaum, M.

Get full text

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever by Rimar, D, Rosner, I, Slobodin, G, Boulman, N, Kaly, L, Rozenbaum, M, Vadasz, Z

Get full text

The patient with supine hypertension and orthostatic hypotension: a clinical dilemma by Naschitz, J E, Slobodin, G, Elias, N, Rosner, I

“…Coexistent supine hypertension and orthostatic hypotension (SH-OH) pose a particular therapeutic dilemma, as treatment of one aspect of the condition may…”
Get full text

Variant CAPS in an adult- the use of genetics by Rozenbam, M, Rimar, D, Kaly, L, Slobodin, G, Awisat, A, Rosner, I

Get full text

Anti-tumor necrosis factor treatment and pregnancy: the way is open by Boulman, N, Rimar, D, Rozenbaum, M, Slobodin, G, Younis, S, Rosner, I

Get full text

The role of regulatory T cells in familial Mediterranean fever (FMF) by Rimar, D., Rosner, I., Slobodin, G., Boulman, N., Toubi, E., Kessel, A., Peri, R., Rozenbaum, M.

“…The role of regulatory T cells (T-regs) in familial Mediterranean fever (FMF) was never evaluated. Preliminary studies that we have conducted suggested a rise…”
Get full text

Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha by Zuckerman, E, Keren, D, Slobodin, G, Rosner, I, Rozenbaum, M, Toubi, E, Sabo, E, Tsykounov, I, Naschitz, J E, Yeshurun, D

“…To assess the benefit of interferon-alpha/ribavirin combination therapy in hepatitis C virus (HCV) infected patients with symptomatic mixed cryoglobulinemia…”
Get more information

Aortic involvement in rheumatic diseases by SLOBODIN, G, NASCHITZ, J. E, ZUCKERMAN, E, ZISMAN, D, ROZENBAUM, M, BOULMAN, N, ROSNER, I

“…To review the prevalence, mechanisms, presentations and clinical significance of aortic involvement in rheumatic inflammatory diseases. The medical literature,…”
Get full text

The clinical phenotype of Israeli patients with Q703K mutation in the NLRP3 gene by Lidar, M, Livneh, A, Zvi, I Ben, Cohen, R, Berkun, Y, Hashkes, P, Peleg, H, Kessel, A, Almog, R, Kali, L, Slobodin, G, Rozenbaum, M, Shinar, Y

Get full text

Mycobacterium fortuitum infection complicating infliximab therapy in rheumatoid arthritis by Boulman, N, Rozenbaum, M, Slobodin, G, Rosner, I

Get full text

Peripheral B‐cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection by ZUCKERMAN, E., SLOBODIN, G., KESSEL, A., SABO, E., YESHURUN, D., HALAS, K., TOUBI, E.

“…SUMMARY Hepatitis C virus (HCV) infection is associated with immune‐mediated abnormalities and B‐cell lymphoproliferation evolving to an overt lymphoma…”
Get full text

Intravenous colchicine treatment for six months: adjunctive therapy in familial Mediterranean fever (FMF) unresponsive to oral colchicine by Rozenbaum, M, Boulman, N, Feld, J, Avshovich, N, Petrovich, S, Elias, M, Slobodin, G, Rosner, I

Get full text

The emergency room in systemic rheumatic diseases by Slobodin, G, Hussein, A, Rozenbaum, M, Rosner, I

“…Complications of systemic rheumatic diseases frequently have protean manifestations and may present a diagnostic problem. Patients with connective tissue…”
Get full text

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-  therapy by Rosner, I., Haddad, A., Boulman, N., Feld, J., Avshovich, N., Slobodin, G., Rozenbaum, M.

Get full text

Hepatitis C virus-related arthritis : Characteristics and response to therapy with interferon alpha by ZUCKERMAN, E, KEREN, D, ROZENBAUM, M, TOUBI, E, SLOBODIN, G, TAMIR, A, NASCHITZ, J. E, YESHURUN, D, ROSNER, I

“…To characterize hepatitis C virus (HCV)-related arthropathy and to evaluate the response to treatment with interferon-alpha (INF-alpha). We studied 28…”
Get full text

Statin escape phenomenon: Does it really exist? by Yeshurun, D., Slobodin, G., Keren, D., Elias, N.

“…The normalization of blood lipid profile has become an accepted method of primary and secondary prevention of vascular disease, with statins being the most…”
Get full text